The Concept of CMR
Slides, videos and more
Editorials from the Chair
November 12, 2013 Eat well, drink well, move… A small step for you, a big step for Europe
News
-
April 18, 2014 Systemic metabolic markers and myocardial glucose uptake in type 2 diabetic and coronary artery disease patients treated for 16 weeks with rosiglitazone, a PPARγ agonist. Ann Med. 2014;46:18-23
Badeau RM, Honka MJ, Lautamäki R, Stewart M, Kangas AJ, Soininen P, Ala-Korpela M, Nuutila P
-
April 18, 2014 Genetic modifiers of cardiorespiratory fitness response to lifestyle intervention. Med Sci Sports Exerc. 2014;46:302-11
Peter I, Papandonatos GD, Belalcazar LM, Yang Y, Erar B, Jakicic JM, Unick JL, Balasubramanyam A, Lipkin EW, Delahanty LM, Wagenknecht LE, Wing RR, McCaffery JM, Huggins GS; Look AHEAD Research Group
-
April 18, 2014 Executive summary: heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation. 2014;129:399-410
Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ, et al.
-
April 17, 2014 Reallocating time to sleep, sedentary behaviors, or active behaviors: associations with cardiovascular disease risk biomarkers, NHANES 2005-2006. Am J Epidemiol. 2014;179:323-34
Buman MP, Winkler EA, Kurka JM, Hekler EB, Baldwin CM, Owen N, Ainsworth BE, Healy GN, Gardiner PA
Subscribe to our Newsletter
Keep up with all the latest from the cardiometabolic world. For breaking news, website updates and exclusive invitations to events with your peers.
CMR Fun Clips
Watch Dr. Cheese and the Potato family’s funny videos and learn simple notions about abdominal obesity and related health.
Calendar of Events
-
May 4 to 7, 2014
Melbourne, Australia World Congress of Cardiology Scientific Sessions -
May 28 to 31, 2014
Sofia, Bulgaria 21st European Congress on Obesity
Recent Contributions
-
Webcasts Prevention of type 2 diabetes: from individual interventions to population-based approaches
The International Chair on Cardiometabolic Risk
-
Expert Opinions Could adipose tissue inflammation eventually be considered as a relevant therapeutic target?
Ulf Smith, MD, PhD, Professor of Internal Medicine, The Lundberg Laboratory for Diabetes Research, Center of Excellence for Cardiovascular and Metabolic Research, Sahlgrenska Academy, Göteborg University, Göteborg, Sweden.
-
Expert Opinions Could you comment on the link between statin use and the risk of developing type 2 diabetes?
Kwang Kong Koh, MD, PhD, FACC, FAHA, Professor, Vascular Medicine and Atherosclerosis Unit Cardiology, Gachon University Gil Medical Center, Incheon, South Korea
In the Spotlight
-
Expert Opinions What is in your opinion the future of cardiovascular disease prevention?
Eric Larose, DVM, MD, Adjunct Professor, Multidisciplinary Department of Cardiology, Institut universitaire de cardiologie et de pneumologie de Québec, Faculty of Medicine, Université Laval, Québec, QC, Canada
-
Slide Library Targeting abdominal obesity in diabetology: What can we do about it?
Luc Van Gaal, MD, PhD, Professor of Medicine, Antwerp University Hospital, Faculty of Medicine, Department of Diabetology, Metabolism & Clinical Nutrition, Antwerp, Belgium
-
Webcasts Dr. Jean-Pierre Després and Ms. Androulla Vassiliou at the September 17, 2013 Special conference - Eat well, drink well, move… A small step for you, a big step for Europe
The International Chair on Cardiometabolic Risk
